Landmark Stockholm3 multi-ethnical trial published in top-ranked Journal of Clinical Oncology
The landmark SEPTA trial, with over 2,000 racially and ethnically diverse biopsied men recruited in the US and Canada has been published in the top ranked oncology journal, Journal of Clinical Oncology. Findings from the SEPTA trial demonstrate the utility and generalizability of Stockholm3 in reducing unneeded biopsies and detecting…